Xaira Therapeutics

About:

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence.

Website: https://xaira.com

Top Investors: Sequoia Capital, Menlo Ventures, New Enterprise Associates, Lightspeed Venture Partners, F-Prime Capital

Description:

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence to learn the language of life and transform how we treat disease. The company seeks to rethink the drug discovery and development process from end-to-end by bringing together leading talent across three core areas: machine learning research to better understand biology, expansive data generation to power new models, and robust therapeutic product development to treat disease. Xaira is headquartered in the San Francisco Bay Area.

Total Funding Amount:

$1B

Headquarters Location:

San Francisco, California, United States

Founded Date:

2024-01-01

Contact Email:

press(AT)xaira.com

Hub Tags:

Unicorn

Founders:

Arvind Rajpal, David Baker, Don Kirkpatrick, Hetu Kamisetty, Joe Watchwell Watson, Marc Tessier-Lavigne

Number of Employees:

51-100

Last Funding Date:

2024-04-23

IPO Status:

Private

© 2024 MyAiNote.com